CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 500 shares at an average $53.10 ($26,548)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale COO,Chief Scientist & Chairman sold 131,386 shares at an average $54.59 ($7,171,768)
- 4 Planned sale COO,Chief Scientist & Chairman sold 219,800 shares at an average $58.23 ($12,798,708)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 500 shares at an average $61.37 ($30,683)
- 144 Insider Sale of Securities
- 4 Open-market sale Senior EVP, Production Center sold 7,830 shares at an average $59.03 ($462,195)
- 4 Planned sale Director sold 500 shares at an average $57.90 ($28,952)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 4,000 shares at $55.86 ($223,446)
- 144 Insider Sale of Securities
Page 11 of 48 · 958 filings